| Filed On | Filing |
|---|---|
| 23 Sep 2022 |
8-K/A: Changes in Registrant's Certifying Accountant; Regulation FD Disclosure
FORT COLLINS, Colo., June 14, 2022 /Globe Newswire/ -- Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration ... |
| 13 Apr 2022 | 8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 08 Mar 2022 | 8-K/A: Results of Operations and Financial Condition; Other Events |
| 12 Nov 2021 | 8-K/A: Submission of Matters to a Vote of Security Holders |
| 30 Jul 2021 | 8-K/A: Financial Statements and Exhibits |
| 21 Jul 2016 | 8-K/A: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 30 Apr 2012 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 26 Feb 2010 | 8-K/A: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
Loading...
